Erasca
ERAS
125 hedge funds and large institutions have $480M invested in Erasca in 2024 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 23 reducing their positions, and 21 closing their positions.
221% more capital invested
Capital invested by funds: $150M → $480M (+$331M)
122% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 23
86% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 21
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
30.24% more ownership
Funds ownership: 48.1% → 78.34% (+30%)
16% more funds holding
Funds holding: 108 → 125 (+17)
84% less call options, than puts
Call options by funds: $79K | Put options by funds: $487K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$35M |
| 2 |
VA
VR Adviser
New York
|
+$35M |
| 3 |
SCM
Suvretta Capital Management
New York
|
+$29.7M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$17.6M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$16.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$12.7M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.97M |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$3M |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$1.96M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.03M |
ERAS Hedge Fund Activity: Q2 2024 in Review
125 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Erasca (ERAS) for Q2 2024, worth a combined $480M — up 221% from $150M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new ERAS positions and 21 closed out — a net gain of 18 holders — while 51 added to existing stakes and 23 trimmed.
The largest buyer was Frazier Life Sciences Management, opening a new position worth an estimated $35M. The largest seller was Armistice Capital, exiting entirely with an estimated $12.7M sold.
- 125 institutional investors held Erasca (ERAS) as of Q2 2024, up from 108 in Q1 2024.
- Funds reported $480M of Erasca stock for Q2 2024, up 221% quarter-over-quarter.
- 39 funds opened new Erasca positions in Q2 2024 and 21 closed out, a net change of +18 holders.
- The largest Erasca buyer in Q2 2024 was Frazier Life Sciences Management, an estimated $35M added.
- The largest Erasca seller in Q2 2024 was Armistice Capital, an estimated $12.7M sold.
Based on aggregated 13F filings for Q2 2024.